At Medlab, we are open to collaboration opportunities to incorporate our research expertise and delivery platform technology to improve patients’ quality of life and health outcomes globally.
Expanding our business in partnership with novel businesses in multiple industries and applications can improve the potentiality of our research and innovations.
Medlab offers a portfolio of ongoing commercial endeavours in which we offer our expertise from concept to produced products.
We are open to Global partnering in the R&D space and licensing our NanoCelle® (drug delivery technology):
- Phase III medicinal cannabinoid + NanoCelle® technology: A non-opioid analgesic for cancer-related bone pain
- NanoCelle®: A sub-micron delivery platform for small molecules
- NanoCelle®: In small molecules with solubility problems
- NanoCelle®: Into a variety of Generic API’s or other suitable molecules
- Nutraceuticals and vitamins solutions internationally
For partnering enquiries and opportunities, please enter and submit your information below.